Brief: Cipher Pharmaceuticals Reports Qtrly Income From Continuing Operations At $0.03 Per Share
10/05/2019 12:17
May 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS FIRST QUARTER 2019
FINANCIAL
RESULTS
* CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE INCREASED
12%
TO $5.1 MILLION
* CIPHER PHARMACEUTICALS INC - QTRLY INCOME FROM CONTINUING
OPERATIONS WAS $0.03 PER SHARE
Source text for Eikon: ID:nCNW89mHTa
Further company coverage: CPH.TO
((Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million